ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
The tablets are indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Dultra added, "We are proud to continue our mission of delivering high-quality, affordable ...
The MarketWatch News Department was not involved in the creation of this content. ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback